Efficacy of infliximab in acute severe ulcerative colitis: A single-centre experience

To suggest infliximab (IFX) is effective for acute severe ulcerative colitis, from real-life clinical practice.All patients receiving IFX for the treatment of acute severe ulcerative colitis in a single centre were included. Data were extracted from clinical records in order to assess response to IFX therapy. The primary endpoint was colectomy-free survival, and secondary outcomes included glucocorticosteroid-free remission and safety, which was...